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Hypoxia exerts profound effects on cell physiology, but its
effect on colonic uptake of the microbiota-generated forms of
vitamin B1 (i.e., thiamin pyrophosphate [TPP] and free thiamine) has not been described. Here, we used human colonic
epithelial NCM460 cells and human differentiated colonoid
monolayers as in vitro and ex vivo models, respectively, and
were subjected to either chamber (1% O2, 5% CO2, and 94% N2)
or chemically (desferrioxamine; 250 μM)-induced hypoxia followed by determination of different physiological–molecular
parameters. We showed that hypoxia causes signiﬁcant inhibition in TPP and free thiamin uptake by colonic
NCM460 cells and colonoid monolayers; it also caused a signiﬁcant reduction in the expression of TPP (SLC44A4) and free
thiamin (SLC19A2 and SLC19A3) transporters and in activity
of their gene promoters. Furthermore, hypoxia caused a signiﬁcant induction in levels of hypoxia-inducible transcription
factor (HIF)-1α but not HIF-2α. Knocking down HIF-1α using
gene-speciﬁc siRNAs in NCM460 cells maintained under hypoxic conditions, on the other hand, led to a signiﬁcant reversal
in the inhibitory effect of hypoxia on TPP and free thiamin
uptake as well as on the expression of their transporters.
Finally, a marked reduction in level of expression of the nuclear
factors cAMP responsive element–binding protein 1 and
gut-enriched Krüppel-like factor 4 (required for activity of
SLC44A4 and SLC19A2 promoters, respectively) was
observed under hypoxic conditions. In summary, hypoxia
causes severe inhibition in colonic TPP and free thiamin
uptake that is mediated at least in part via HIF-1α-mediated
transcriptional mechanisms affecting their respective
transporters.

Vitamin B1, a water-soluble micronutrient, is essential for
normal physiology and health of all human/mammalian cells.
In its predominant and biologically active form, that is, thiamin
pyrophosphate (TPP), the vitamin plays indispensable roles in
oxidative energy metabolism–ATP production and in
* For correspondence: Hamid M. Said, hmsaid@uci.edu.

reduction of cellular oxidative stress. Thus, it is not surprising
that deﬁciency of vitamin B1 at the cellular and systemic levels
negatively impacts cell physiology and overall host health. At
the cellular level, such deﬁciency leads to impairment in
oxidative energy metabolism, ATP production, disruption in
mitochondrial function (mitochondria utilize 90% of cellular
TPP), oxidative stress, and apoptosis (1–5). At the systemic
level, the deﬁciency leads to a variety of clinical abnormalities
(e.g., neurological and cardiovascular disorders). Vitamin B1
deﬁciency is not uncommon and occurs in different conditions, including inﬂammatory bowel disease (IBD) (6), sepsis
(7), chronic alcoholism (8, 9), bariatric surgery (10), and
diabetes mellitus (11). Optimizing thiamin body level/homeostasis, on the other hand, has been shown to be beneﬁcial
in treating disorders like sepsis/septic shock (7, 12) and
thiamin-responsive megaloblastic anemia (13); it also reduces
fatigue in IBD patients (14).
Humans and other mammals obtain vitamin B1 (via intestinal absorption) from exogenous sources as they cannot
synthesize it endogenously. Two sources of thiamin are
available to the gut: diet and the gut microbiota (15–20). In the
diet, vitamin B1 exists in both the free and phosphorylated
forms; the latter form is enzymatically converted (by the action
of small intestinal phosphatases) to the free form (i.e., free
thiamin) prior to absorption (reviewed in Ref. (20)). Free
thiamin is then absorbed by a speciﬁc carrier-mediated
mechanism that involves two transporters: thiamin
transporter-1 (THTR-1) and thiamin transporter-2 (THTR-2);
products of the SLC19A2 and SLC19A3 genes, respectively;
reviewed in Ref. (21)). Microbiota-generated vitamin B1 provides both free thiamin and TPP forms (15–17), and several
phyla (including Bacteroidetes [Bacteroides fragilis and Prevotella copri], Firmicutes [Clostridium difﬁcile, Ruminococcus
lactaris, and some Lactobacillus sp.], Actinobacteria [Biﬁdobacterium sp.], and Fusobacter [Fusobacterium varium])
appear to be the main producers of the vitamin (22). Studies
with human subjects and rodents have shown that the large
intestine is capable of absorbing luminal vitamin B1 (reviewed
in Ref. (17); also Refs. (18, 23, 24)). This was conﬁrmed in
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Effect of hypoxia on colonic TPP and free thiamin uptake
studies in our laboratory utilizing human colonic epithelial
cells and colonic apical membrane vesicle preparations isolated from the colon of organ donors (19, 25, 26). The latter
studies have shown that colonic uptake of free thiamin is
similar to that in the small intestine and occurs via a carriermediated process that involves THTR-1 and THTR-2 (19).
Colonic uptake of TPP, on the other hand, was found to occur
via a distinct and an efﬁcient carrier-mediated process that
involves the colonic TPP transporter (cTPPT; product of the
SLC44A4 gene (25, 26)). Expression of the cTPPT in the intestinal tract is limited to the large bowel (27, 28) and occurs
exclusively at the apical membrane domain of the lining
polarized epithelia (25–27). Since colonocytes have limited
ability to generate TPP intracellularly (they express a very low
level of the required enzyme, that is, TPKase; (28)), the cTPPT
system appears to be of dual importance: it provides the
metabolically active colonocytes with their need of an already
synthesized TPP and also contributes toward total body
nutrition/homeostasis of vitamin B1 (29, 30).
Epithelial cells lining the intestinal tract are exposed to
changing levels of oxygen because of their juxtaposition to the
oxygen-depleted (anerobic/anoxic) gut lumen and because of
the constantly changing rates of oxygen demand/supply (31,
32). This austere microenvironment (considered to be among
the most severe in mammalian tissues) leads to a state of
hypoxia even under physiologic conditions. Inﬂammation in
the colonic and small intestinal mucosa (as in IBD), however,
leads to the development of a more profound and severe form
of hypoxia, the so-called pathophysiologic hypoxia (31–34).
Pathophysiologic hypoxia exerts profound effects on the cell
physiology including their transport functions; the effect on
the latter, however, is differential, and both stimulation and
inhibition have been reported (35–40). Nothing is currently
known about the effect of hypoxia on colonic uptake of
microbiota-generated vitamin B1 forms (i.e., TPP and free
thiamine). We addressed this issue using an in vitro (human
colonic epithelial NCM460 cells) and an ex vivo (human
differentiated colonoid monolayers) model. Our results
showed that hypoxia causes signiﬁcant inhibition in colonic
uptake of TPP and free thiamin. This inhibition is associated
with a marked reduction in level of expression of cTPPT,
THTR-1, and THTR-2 and appears to be mediated (at least in
part) via transcriptional mechanism(s) involving the SLC44A4,
SLC19A2, and SLC19A3 genes.

Results
Effect of hypoxia on colonic uptake of TPP and free thiamin
Effect of chamber-induced hypoxia
In these studies, we used in vitro and ex vivo models to
examine the effect of chamber-induced hypoxia on colonic
carrier–mediated uptake of TPP and free thiamin. In the
in vitro model, we exposed human colonic epithelial
NCM460 cells to hypoxia by maintaining the cells for 16 h in a
hypoxic chamber (see the “Experimental procedures” section).
First, we veriﬁed that hypoxia was induced in the cells incubated under the hypoxic condition by assessing the level of
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expression of a positive internal control: phosphoglycerate
kinase 1 (PGK-1), an enzyme is known to be induced under
hypoxic conditions (41). The results showed a marked induction in level of mRNA expression of marker genes in cells
incubated under hypoxic compared with normoxic conditions
(mRNA levels of PGK-1 were 100 ± 20 and 370 ± 10 in cells
maintained under normoxic and hypoxic conditions, respectively. p < 0.05). We then examined the effect of chamberinduced hypoxia on initial rate of carrier-mediated uptake of
TPP (0.23 μM) and free thiamin (15 nM) in NCM460. Hypoxia
resulted in signiﬁcant (p < 0.01 for both) inhibition in cellular
uptake of both TPP and free thiamin relative to normoxia
(Fig. 1, A-[i] and B-[i]). In both cases, the inhibition was found
to be associated with a marked reduction in level of expression
of the involved transporters (i.e., cTPPT for TPP and THTR-1
and THTR-2 for free thiamin) at both the protein and mRNA
levels (Fig. 1, A-[ii] and [iii] and B-[ii]–[v]).
To establish translational relevance to the ﬁndings on the
effect of hypoxia on colonic carrier–mediated TPP and free
thiamin uptake observed with cultured NCM460 cells, we
examined the effect of chamber-induced hypoxia on carriermediated uptake of these two forms of vitamin B1 using the
ex vivo human differentiated colonoid monolayers. The results
again showed signiﬁcant inhibition in carrier-mediated TPP
(p < 0.05) and free thiamin (p < 0.01) uptake by colonoid
monolayers maintained under hypoxic compared with normoxic conditions. This inhibition was similarly associated with
a signiﬁcant reduction in mRNA expression of the respective
transporters (for cTPPT, p < 0.01; THTR-1, p < 0.01; and
THTR-2, p < 0.05) in hypoxia-exposed colonoid monolayers
compared with normoxia (Fig. 2, A and B).
Taken together, the aforedescribed ﬁndings show that
exposure of human colonic epithelial cells to hypoxia signiﬁcantly impairs uptake of the microbiota-generated TPP and
free thiamin and that the effect is mediated via reduction in
level of expression of their respective uptake systems.
Effect of chemically induced hypoxia
In these studies, we examined the effect of chemically
induced hypoxia on initial rate of colonic carrier–mediated
uptake of TPP and free thiamin. For this, we treated human
colonic epithelial NCM460 cells with the hypoxia-mimetic
agent desferrioxamine (DFO) (250 μM for 48 h; (38)) followed by transport investigations. First, we veriﬁed induction
of hypoxia in the DFO-treated cells by assessing level of
expression of two positive internal controls: lactate dehydrogenase A (LDHA) and PGK-1 (41). DFO treatment resulted in
a marked induction in mRNA expression of both enzymes
compared with untreated control cells. (Relative expression
levels of LDHA: 100 ± 5 and 598 ± 33 and PGK-1: 100 ± 2.4
and 650 ± 18 in control and DFO-treated cells, respectively;
p < 0.01 for both). We then examined the effect of chemically
induced hypoxia on carrier-mediated TPP (0.23 μM, 7 min)
and free thiamin (15 nM, 10 min) uptake. Again, we observed
signiﬁcant (p < 0.05 for both) inhibition in carrier-mediated
TPP and free thiamin uptake in DFO-treated cells compared
with untreated controls (Fig. 3, A-[i] and B-[i]). This inhibition
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Figure 1. Effect of chamber-induced hypoxia on TPP and free thiamin uptake by human colonic epithelial NCM460 cells. Cells were exposed to
chamber-induced hypoxia for 16 h. A, effect of hypoxia on [i] carrier-mediated [3H]-TPP uptake; [ii] and [iii] level of expression of cTPPT protein and mRNA,
respectively. B, effect of hypoxia on [i] carrier-mediated [3H]-thiamin uptake; [ii] and [iii] level of expression of THTR-1 and THTR-2 proteins (immunoblot);
and [iv] and [v] level of expression of THTR-1 and THTR-2 mRNAs (RT–qPCR), respectively. All protein and mRNA results were normalized relative to GAPDH,
and comparison was made relative to simultaneously performed controls (normoxia). Statistical signiﬁcance of uptake (n = 6; **p < 0.01), protein (n = 4;
**p < 0.01), and mRNA (n = 3; **p < 0.01) was evaluated by the Student’s t test. cTPPT, colonic TPP transporter; THTR-1, thiamin transporter-1; THTR-2,
thiamin transporter-2; TPP, thiamin pyrophosphate; qPCR, quantitative PCR.

was associated with marked (p < 0.01 for all) reduction in level
of mRNA expression of cTPPT, THTR-1, and THTR-2 in
hypoxic compared with normoxic cells (Fig. 3, A-[ii] and B[ii]–[iii]).
Collectively, the aforementioned ﬁndings show that
chamber-induced and chemically induced hypoxia inhibits
colonic carrier–mediated uptake of TPP and free thiamin, and
that the inhibition is associated with reduction in level of
expression of TPP and free thiamin transporters.

SLC19A2, and SLC19A3 full-length (as well as minimal) promoters compared with normoxic conditions (Fig. 4, A–C).
These ﬁndings suggest that transcriptional mechanisms
mediate the effects of hypoxia on carrier-mediated TPP and
free thiamin uptake by human colonocytes. The data also
demonstrate that the hypoxia-responsive regions are in the
minimal promoter regions of these genes.

Effect of hypoxia on the activity of the SLC44A4, SLC19A2,
and SLC19A3 gene promoters in colonic epithelial cells:
involvement of transcriptional mechanism(s)

Cellular responses to hypoxia are primarily mediated by
hypoxia-inducible transcription factors (HIFs), especially HIF1α and HIF-2α (42, 43). In this study, we examined the effect of
chamber-induced hypoxia on level of expression of these factors in human colonic epithelial NCM460 cells. First, we
subjected the SLC44A4, SLC19A2, and SLC19A3 minimal
promoter regions to computer analysis (Eukaryotic Promoter
Database; https://epd.epﬂ.ch//index.php) to determine if they
contain putative hypoxia-responsive element (HRE)–binding
sites (i.e., “R-CGTG”). The computational analysis predicted
the SLC44A4 and SLC19A2 minimal promoters to contain one
putative HRE sequence at position −55 and −141, respectively.
The minimum promoter of SLC19A3, on the other hand, was
found to contain three such putative HRE sequences located at

The aforeobserved inhibition in colonic carrier–mediated
uptake of TPP and free thiamin and in the level of mRNA
expression of the involved transporters suggests possible
involvement of transcriptional mechanism(s) involving the
SLC44A4, SLC19A2, and SLC19A3 genes. To test this possibility, we exposed colonic epithelial NCM460 cells transfected
with SLC44A4, SLC19A2, and SLC19A3 full-length (as well as
minimal) promoters fused to the luciferase reporter gene to
chamber-induced hypoxia followed by examination of promoter activities. Exposure of cells to hypoxia resulted in
signiﬁcantly (p < 0.01 for all) reduced activity of SLC44A4,

Effect of chamber-induced hypoxia on level of expression of
hypoxia-inducible transcription factors in human colonocytes
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Figure 2. Effect of chamber-induced hypoxia on TPP and free thiamin uptake by human differentiated colonoid monolayers. Colonic monolayers
were exposed to chamber-induced hypoxia for 16 h. A, effect of hypoxia on [i] colonic carrier–mediated [3H]-TPP uptake; [ii] level of expression of cTPPT
mRNA. B, effect of hypoxia on [i] colonic carrier–mediated [3H]-thiamin uptake; [ii] and [iii] level of expression of THTR-1 and THTR-2 mRNAs, respectively. All
mRNA results were normalized relative to GAPDH, and comparison was made relative to simultaneously performed controls (normoxia). Statistical
signiﬁcance of all uptake and mRNA data (n = 3 for all; **p < 0.01; *p < 0.05, respectively) was evaluated by the Student’s t test. cTPPT, colonic TPP
transporter; THTR-1, thiamin transporter-1; THTR-2, thiamin transporter-2; TPP, thiamin pyrophosphate.

positions −44, −47, and −73 (Fig. 5A). We then examined (by
immunoblotting) the effect of chamber-induced hypoxia on
level of expression of HIF-1α and HIF-2α proteins in human
colonic epithelial NCM460 cells; results were compared with
their level of expression in control cells maintained under
normoxic condition. Detectable levels of HIF-1α in hypoxic
cells (but not those maintained under normoxic condition)
increased with time with hypoxia (Fig. 5B-[i]). On the other
hand, the very low level of HIF-2α protein detected in colonic
NCM460 cells maintained under hypoxic conditions was
similar to that in cells maintained under control (normoxic)
conditions (Fig. 5B-[ii]). These ﬁndings suggest a role for HIF1α in mediating the inhibitory effect of hypoxia on colonic
uptake of TPP and free thiamin.

Role of HIF-1α in mediating the inhibitory effect of hypoxia on
colonic uptake of TPP and free thiamin and on expression of
cTPPT, THTR-1, and THTR-2
To further conﬁrm the contribution of HIF-1α in mediating
the inhibitory effect of hypoxia on carrier-mediated colonic
TPP and free thiamin uptake and expression of their relevant
transporters, we examined the effect of siRNA silencing on the
HIF-1α gene (44) in NCM460 cells maintained under
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chamber-induced hypoxia on their ability to take up TPP and
free thiamin. First, we established that in hypoxic
NCM460 cells, HIF-1α gene-speciﬁc siRNA leads to signiﬁcant
(p < 0.01) inhibition in level of expression of HIF-1α protein
(Fig. 6A). Under chamber-induced hypoxia, HIF-1α-speciﬁc
siRNA treatment of NCM460 cells led to a signiﬁcant (p <
0.01–0.05) recovery in transport of both TPP and free thiamin
substrates relative to uptake by cells treated with scrambled
siRNAs (Fig. 6, B and C). Similarly, expression of the corresponding cTPPT (p < 0.05), THTR-1 (p < 0.01), and THTR-2
(p < 0.01) proteins was enhanced under hypoxic conditions in
NCM460 cells pretreated with HIF-1α siRNAs compared with
cells pretreated with scrambled siRNA (Fig. 6, D–F). These
ﬁndings demonstrate that HIF-1α mediates the inhibitory effects of hypoxia on colonic carrier–mediated uptake of TPP
and free thiamin and on levels of expression of their relevant
transporters.

Effect of hypoxia on expression of nuclear factors required for
basal activity of the SLC44A4, SLC19A2, and SLC19A3 gene
promoters
The aforedescribed studies demonstrate that hypoxia
negatively impacts colonic uptake of TPP and free thiamin as
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Figure 3. Effect of chemically induced hypoxia on uptake of TPP and free thiamin by human colonic epithelial NCM460 cells. Cells were treated with
the hypoxia-mimetic agent DFO (250 μM) for 48 h. A, effect of hypoxia on [i] colonic carrier–mediated [3H]-TPP uptake and [ii] level of expression of cTPPT
mRNA. B, effect of hypoxia on [i] colonic carrier–mediated [3H]-thiamin uptake; [ii] and [iii] level of expression of THTR-1 and THTR-2 mRNA, respectively. All
mRNA results were normalized relative to GAPDH, and comparison was made relative to simultaneously performed controls (normoxia). Statistical
signiﬁcance of uptake (n = 4; *p < 0.05) and mRNA (n = 4; **p < 0.01) was evaluated by the Student’s t test. cTPPT, colonic TPP transporter; DFO,
desferrioxamine; THTR-1, thiamin transporter-1; THTR-2, thiamin transporter-2; TPP, thiamin pyrophosphate.

well as expression of their transporters, and that the effect is
mediated via transcriptional modulation of the SLC44A4,
SLC19A2, and SLC19A3 genes. Whether part of the effect of
hypoxia on transcription of these genes is also mediated
through inhibited expression of nuclear factor(s) required for
basal activity of their promoters is not clear. Thus, we examined the effect of chamber-induced hypoxia on level of
expression of the transcription factors cAMP responsive
element–binding protein (CREB), E74-like ETS transcription
factor 3 (Elf-3), speciﬁcity protein 1 (SP-1), gut-enriched
Krüppel-like factor 4 (GKLF-4), and neuroﬁbromatosis-1
(NF-1) in human colonic NCM460 cells as well as human
differentiated colonoid monolayers. We focused on these
transcription activators because previous studies from our
laboratory have shown that the minimal promoter regions of
the SLC44A4, SLC19A2, and SLC19A3 genes contain cis-elements for these nuclear factors that are important for their
activity (the minimal promoter region of SLC44A4 contains
CREB [−35] and Elf-3 [−77]; that of SLC19A2 contains SP-1
[−238], GKLF-4 [−305], NF-1 [−350]; and that of SLC19A3
contains an SP-1 [−45]) (43–45). Results of the quantitative
PCR (qPCR) analysis showed signiﬁcant (p < 0.01 for both)
reduction in level of mRNA expression of the CREB-1 and
GKLF-4 (but not that of Elf-3, SP-1, or NF-1A) in human

colonic epithelial NCM460 cells (Fig. 7A) as well as human
colonoid monolayers (Fig. 7B) maintained under hypoxic
condition compared with those maintained under normoxic
condition.

Discussion
Our aims in these investigations were to examine the effects
of pathophysiological hypoxia on colonic uptake of the
microbiota-generated TPP as well as free thiamin. As
mentioned earlier, hypoxia exerts profound effects on cell
physiology including transport events at their cell membranes
(35–40). Nothing, however, is known about the effect of
hypoxia on colonic uptake of vitamin B1, a micronutrient that
is essential for cellular energy metabolism/ATP production,
mitochondrial function, and for reduction of oxidative stress
(1–4). We investigate this issue utilizing two complementary
models of human colonic epithelial cells: an in vitro (human
epithelial NCM460 cells) and an ex vivo (human differentiated
colonoid monolayers) model. Also, we employed two models
of hypoxia in our investigations: chamber-induced as well as
chemically induced hypoxia.
Results of our investigations showed that exposure of human colonic epithelial NCM460 cells to chamber-induced or
to chemically induced hypoxia lead to a signiﬁcant inhibition
J. Biol. Chem. (2022) 298(2) 101562
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Figure 4. Effect of exposure of human colonic epithelial NCM460 cells to chamber-induced hypoxia on promoter activity. A, SLC44A4; B, SLC19A2;
and C, SLC19A3 genes. Full-length and minimal-promoter constructs of the respective genes in pGL3 basic vector with pRLTK plasmid were transfected into
NCM460 cells. Forty-eight hours following transfection, cells were exposed to chamber-induced hypoxia for additional 16 h followed by the determination
of luciferase activity. All luciferase activities were normalized relative to PGL3 basic vector, and comparison was made relative to simultaneously performed
controls (normoxia). Statistical signiﬁcance of all data (n = 8 for all; **p < 0.01) were evaluated by the Student’s t test. pRLTK, thymidine kinase promoterRenilla luciferase.

in carrier-mediated TPP and free thiamin uptake. This inhibition was associated with a signiﬁcant reduction in level of
expression of cTPPT as well as THTR-1 and THTR-2 proteins
and mRNAs. Similar ﬁndings were observed when human
differentiated colonoid monolayers were exposed to chamberinduced hypoxia, where a signiﬁcant inhibition in carriermediated TPP and free thiamin uptake occurred that was
associated with a signiﬁcant reduction in level of expression of
cTPPT and THTR-1 and THTR-2.

The inhibitory effects of hypoxia on colonic TPP and free
thiamin uptake and expression of their transporters were
found to be mediated (at least in part) via transcriptional
mechanisms affecting the respective genes of the involved
transporters. This was evident from the results of studies of the
effect of chamber-induced hypoxia on activity of the SLC44A4,
SLC19A2, and SLC19A3 promoters (both full-length and
minimal promoters), where signiﬁcant inhibition in activity of
these promoters was observed in colonic epithelial cells

Figure 5. Effect of hypoxia on chamber-induced hypoxia on level of expression of hypoxia-inducible factors (HIFs) in human colonic epithelial
NCM460 cells. A, schematic representation of the [i] SLC44A4, [ii] SLC19A2, and [iii] SLC19A3 minimal promoter regions depicting predicted binding sites for
HREs. B, NCM460 cells were exposed to chamber-induced hypoxia for 16 h followed by examination of HIF expression. Level of expression of HIF-1α and
HIF-2α protein (immunoblot) in hypoxia-exposed cells compared with those exposed to normoxia (control) condition. All protein results were normalized
relative to GAPDH. Statistical signiﬁcance of all proteins (n = 3; *p < 0.05) was evaluated using the Student’s t test. HRE, hypoxia-responsive element.
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Figure 6. Effect of hypoxia on knocking down HIF-1α with gene-speciﬁc siRNA on the inhibitory effect of hypoxia on uptake of TPP and free
thiamin and on the level of expression of cTPPT, THTR-1, and THTR-2 in human colonic epithelial NCM460 cells. Cells were transfected with
prevalidated HIF-1α-speciﬁc or scrambled (nontargeting negative control) siRNAs (42) as described in the Experimental procedures section. Twenty four
hours following transfection, cells were exposed to normoxic or hypoxic conditions for an additional 16 h. A, immunoblot showing the effect of transfection
with HIF-1α-speciﬁc and scrambled siRNAs on level of expression of the HIF-1α protein (probing was done using speciﬁc anti-HIF-1α antibody). B, initial rate
(7 min) of carrier-mediated [3H]-TPP uptake. C, initial rate (10 min) of carrier-mediated [3H]-thiamin uptake. D–F, level of expression of cTPPT, THTR-1, and
THTR-2 proteins (immunoblot) probed with the transporter-speciﬁc antibodies (see the Experimental procedures section). All protein results were
normalized relative to GAPDH, and comparison was made relative to simultaneously performed controls (normoxia). Statistical signiﬁcance of uptake (n = 4;
**p < 0.01; *p < 0.05) and protein (n = 3; **p < 0.01; *p < 0.05) data was evaluated by the Student’s t test. cTPPT, colonic TPP transporter; HIF-1α, hypoxiainducible transcription factor 1α; THTR-1, thiamin transporter-1; THTR-2, thiamin transporter-2; TPP, thiamin pyrophosphate.

exposed to hypoxia compared with those maintained under
normoxic conditions. The fact that hypoxia caused a similar
degree of inhibition in activity of full-length as well as minimal
promoters of these genes suggests that the HREs are located in
latter regions. Indeed, interrogation of the minimal promoter
regions of SLC44A4, SLC19A2, and SLC19A3 by the Eukaryotic Promoter Database program predicted existence of HREs
in all these regions. Since cellular responses to hypoxia are
mainly mediated by HIF-1α and HIF-2α (42, 43), we examined
the effect of chamber-induced hypoxia on level of expression
of these factors in human colonic epithelial NCM460 cells.
The results showed induction in level of expression of HIF-1α
(but not HIF-2α) in cells exposed to hypoxia, which increased
with time. These ﬁndings suggested a role for HIF-1α in
mediating the effect of hypoxia on colonic TPP and free
thiamin uptake and expression of their respective transporters.
The latter suggestion was conﬁrmed in the study examining
the effect of knocking down HIF-1α of NCM460 cells with
gene-speciﬁc siRNAs on the hypoxia-mediated inhibition of
TPP and free thiamin uptake and expression of their

transporters. Indeed, a signiﬁcant reversal in the inhibitory
effect of hypoxia on colonic TPP and free thiamin uptake as
well as on level of expression of cTPPT, THTR-1, and THTR-2
proteins was observed as a result of HIF-1α knockdown. These
ﬁndings clearly establish a role for HIF-1α in mediating the
inhibitory effect of hypoxia on colonic uptake of TPP and free
thiamin.
Previous studies from our laboratory have established that
transcription factors, CREB-1, Elf-3, GKLF4, NF-1, and SP1,
play an important role in driving the activity of the SLC44A4,
SLC19A2, and SLC19A3 promoters (45–47). Thus, we also
examined whether part of the hypoxia effects on colonic TPP
and free thiamin uptake and expression of their transporters
could also involve suppression in level of expression of these
nuclear factors. The results indeed showed signiﬁcant suppression in level of expression of CREB-1 and GKLF-4 (with
no effect on level of expression of Elf-3, SP-1, or NF-1A) in
NCM460 cells and human differentiated colonoid monolayers
exposed to hypoxia compared with those maintained under
normoxic condition. These ﬁndings suggest possible
J. Biol. Chem. (2022) 298(2) 101562
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Figure 7. Effect of chemically induced hypoxia on expression of transcription factors (TFs) that regulate activity of the SLC44A4, SLC19A2, and
SLC19A3 gene promoters. A, human colonic epithelial NCM460 cells. B, human differentiated colonoid monolayers. NCM460 cells and human differentiated colonoid monolayers were exposed to hypoxic (or normoxic) conditions, followed by determination of levels of mRNA expression of the TFs CREB-1
and Elf-3 (for SLC44A4 promoter) as well as SP1, GKLF4, and NF-1A (for SLC19A2 and SLC19A3 promoters). All mRNA expression data were normalized relative
to GAPDH and compared with their respective controls (n = 3; **p < 0.01). Statistical signiﬁcance was evaluated by Student’s t test. CREB-1, cAMP responsive
element–binding protein 1; Elf-3, E74-like ETS transcription factor 3; GKLF-4, gut-enriched Kruppel-like factor 4; NF-1A, neuroﬁbromatosis-1A; NS, not
signiﬁcant; SP1, speciﬁcity protein 1.

involvement of CREB-1 and GKLF4 in mediating (part of) the
inhibitory effect of hypoxia on cTPPT and THTR-1 expression
and ultimately colonic TPP and thiamin uptake. Whether the
reduction in level of expression of the latter transcription
factors is mediated via HIF-1α or other hypoxia-mediated
mechanisms is not known at this stage requires further
investigations.
Our ﬁndings of inhibition in uptake of free thiamin and
expression of its transporters in human colonocytes are in
contrast to the stimulatory effect of hypoxia on vitamin B1
uptake and expression of THTR-1 observed in breast cancer
cells (38). This suggests that the effects of hypoxia on vitamin
B1 transport are cell speciﬁc in nature. In summary, our
ﬁndings show for the ﬁrst time that exposure of human
colonocytes to hypoxia negatively impacts the transport
physiology and molecular biology of TPP and free thiamin
uptake processes. The results also show that these effects are
mediated (at least in part) at the level of transcription of the
SLC44A4, SLC19A2, and SLC19A3 genes.

Experimental procedures
Chemicals and reagents
[3H]-TPP (speciﬁc activity: >1.4 Ci/mmol; radiochemical
purity: >98.2%) and [3H]-thiamin (speciﬁc activity: >12.8 Ci/
mmol; radiochemical purity: >93.3%) were purchased from
Moravek, Inc. Human-speciﬁc anti-TPPT (SLC44A4) afﬁnitypuriﬁed rabbit polyclonal antibody was generated for us by
Thermo Fisher Scientiﬁc; anti-THTR-1 (catalog no.:
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ab229680) rabbit polyclonal antibody was from Abcam; antiTHTR-2 (catalog no.: 13407-1-AP) rabbit polyclonal antibody was from Proteintech; anti-HIF-1α (catalog no.: 14179S)
rabbit monoclonal antibody was from Cell Signaling Technology; anti-HIF-2α (catalog no.: NB100-122) rabbit polyclonal antibody was from Novus Biologicals; and anti-GAPDH
mouse monoclonal antibody (catalog no.: sc-47724) was from
Santa Cruz. The secondary antibodies, anti-rabbit IRDye-800
(catalog no.: 926-32211) and antimouse IRDye-680 (catalog
no.: 926-68020), were purchased from LI-COR Bioscience. All
other chemicals and reagents used in this studies were of
analytical/molecular biology grade and purchased from
established sources.
Culturing of human-derived colonic epithelial NCM460 cells
and exposure to hypoxia
NCM460 cells were obtained from INCELL and maintained
in M3 base culture medium, supplemented with fetal bovine
serum (20%), penicillin (100 U/ml), and streptomycin (100 μg/
ml) and incubated at 37  C in 5% CO2 incubator as described
before. Our selection of the NCM460 cells as the model in the
current investigation is based on the fact that they are similar
to native human colonic preparations in that they transport
TPP and free thiamin via distinct and speciﬁc carrier-mediated
processes (19, 21, 25, 26). Also, our ﬁndings on the effect of
hypoxia were not unique to these cells but were also observed
with the human colonic epithelial CCD 841 cells (data not
shown). In these studies, we grew the NCM460 cells to 70 to
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Table 1
List of primer sequences for RT–qPCR
Gene name
Human
Human
Human
Human
Human
Human
Human
Human
Human
Human
Human

cTPPT
THTR-1
THTR-2
CREB-1
Elf-3
SP-1
GKLF-4
NF-1A
GAPDH
PGK-1
LDHA

Forward primers (50 –30 )

Reverse primers (50 —30 )

TGCTGATGCTCATCTTCCTGCG
GCCAGACCGTCTCCTTGTA
TTCCTGGATTTACCCCACTG
TTAACCATGACCAATGCAGCA
TCTTCCCCAGCGATGGTTTTC
CCATACCCCTTAACCCCG
CCGCTCCATTACCAAGAGCT
GCAGGCCCGAAAACGAAAATA
CGACCACTTTGTCAAGCTCA
TTAAAGGGAAGCGGGTCGTTA
CTCCAAGCTGGTCATTATCACG

GGACAAAGGTGACCAGTGGGTA
TAGAGAGGGCCCACCACAC
GTATGTCCAAACGGGGAAGA
TGGTATGTTTGTACGTCTCCAGA
TCCCGGATGAACTCCCACA
GAATTTTCACTAATGTTTCCCACC
ATCGTCTTCCCCTCTTTGGC
TTTGCCAGAAGTCGAGATGCC
AGGGGAGATTCAGTGTGGTG
TCCATTGTCCAAGCAGAATTTGA
AGTTCGGGCTGTATTTTACAACA

80% conﬂuency, then maintained them (for the indicated periods) under either a standard normoxic, that is, control (humidiﬁed air with 5% CO2; ThermoFisher Forma Series II
incubator) or hypoxic (1% O2, 94% N2, and 5% CO2; Thermo
Scientiﬁc HERACELL150i incubator) conditions. Chemical
hypoxia was induced in NCM460 cells by incubating them in
the presence of 250 μM DFO (a hypoxic-memetic agent that
chelates iron and prevents the degradation of HIF-1α protein
leading to hypoxia; (38, 48)) for 48 h; control cells were run
simultaneously and maintained in the absence of DFO.

The radioactive content was counted using a liquid scintillation
counter as described previously (50). Uptake of TPP and free
thiamin by their respective and distinct carrier-mediated
mechanism was determined by subtracting uptake of
[3H]-TPP or free [3H]-thiamin in the presence of a high pharmacological concentration (1 mM) of unlabeled TPP or free
thiamin from uptake in their absence; all uptake data points were
calculated relative to total protein content (in milligrams) of the
different preparations.
siRNA transfection

Culturing of human differentiated colonoid monolayers and
exposure to hypoxia
Human colonoids were prepared from biopsy samples of
adult healthy individuals at the Digestive Diseases Research
Center of the Washington University, School of Medicine and
were grown as previously described (49, 50). Brieﬂy, isolated
colonoids were thawed and plated (in 24-well plates) in
Matrigel (BD Biosciences) droplets (15 μl) followed by incubation at 37  C with conditioned media (a 1:1 mixture of the
L-WRN cell line and primary culture media [Advanced
DMEM/F12; Invitrogen] supplemented with fetal bovine
serum [20%], L-glutamine [2 mM], penicillin [100 U/ml],
streptomycin [100 μg/ml], Stemolecule Y27632 [10 μM;
Reprocell], and SB 431542 [10 μM; Peprotech]). To obtain
polarized differentiated colonoid monolayers, cells were plated
at density of 5 × 104 cells/well onto 24-well cell culture inserts
(Corning) coated with type IV human collagen (Sigma) and
then grown for 4 days prior to induction of differentiation by
addition of differentiation media (5% conditioned media added
with only Y-27632 inhibitor). Differentiated colonoid monolayers were then exposed as indicated to normoxia and hypoxia conditions as mentioned previously.
Carrier-mediated [3H]-TPP and [3H]-thiamin uptake
Initial rates (10 min for in vitro; 30 min for ex vivo; both at
37  C) of carrier-mediated TPP and free thiamin uptake were
examined in normoxic and hypoxic NCM460 cells (in vitro) as
well as differentiated colonoid monolayers (ex vivo) incubated in
Krebs–Ringer buffer (pH 7.4) containing [3H]-TPP (0.23 μM) or
[3H]-thiamin (15 nM). At the end of incubations, cells/monolayers were then washed with ice-cold Krebs–Ringer buffer
followed by lysis with NaOH and neutralization with 10 N HCl.

A well-validated silencer-select siRNA targeting HIF-1α
(s6541) and negative control siRNA (catalog no.: 4390843) (44)
were obtained from Thermo Fisher Scientiﬁc. NCM460 cells
were transfected with siRNAs for 24 h using Lipofectamine
RNAiMAX transfection reagent (Invitrogen) following the
manufacturer’s instructions. During transfection, the culture
medium containing the siRNA and transfection reagent was
changed daily. After transfection, the cells were exposed to
normoxic or hypoxic conditions for an additional 16 h.
Isolation of RNA, complementary DNA synthesis, and real-time
qPCR assay
Total RNA was isolated from human colonic epithelial
NCM460 cells and human differentiated colonoid monolayers
using QIAzol Lysis reagent (QIAGEN) and RNeasy Kit
(QIAGEN) as previously described (50). The RNA was then
converted to complementary DNA using the Verso-cDNA
Synthesis Kit (Thermo Fisher Scientiﬁc), and levels of mRNA
expression of SLC44A4, SLC19A2, SLC19A3, CREB-1, Elf-3,
SP-1, GKLF, NF-1, PGK-1, and LDHA were then quantiﬁed by
real-time qPCR using iQ SYBER Green Super mix (Bio-Rad) in
the CFX96 real-time PCR system (Bio-Rad) following the
manufacturer’s guidelines using gene-speciﬁc primers
(Table 1). Relative gene expression was quantiﬁed by
normalizing threshold cycle (Ct) values to the respective
GAPDH following 2−ΔΔCt method (51).
Isolation of protein and immunoblotting assay
Total protein was isolated from human colonic
NCM460 cells using radioimmunoprecipitation assay buffer
(Sigma) with protease inhibitor cocktail, and an equal amount
(45 μg) of the proteins was loaded on a NuPAGE 4 to 12%
J. Biol. Chem. (2022) 298(2) 101562
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Bris–Tris gradient minigels (Invitrogen) as previously
described (47). The proteins were then blotted onto polyvinylidene diﬂuoride membranes and probed with anti-cTPPT
(1:500), anti-THTR-1 (1:1000), anti-THTR-2 (1:1000), antiHIF-1α (1:500), or anti-HIF-2α (1:500) antibodies and simultaneously with anti-GAPDH (1:2000) primary antibodies.
Speciﬁcity of the anti-cTPPT, THTR-1, and THTR-2 antibodies was validated in our laboratory previously using
different approaches that include overexpression of tag protein
or gene silencing (52, 53). Other antibodies were validated by
either the respective company or by the other investigators
using knockout animals and/or gene knockdown approaches.
The immune-reactive bands from the blot were then identiﬁed
with corresponding anti-rabbit IR-800 dye (1:30,000) and
antimouse IR-680 dye (1:30,000) secondary antibodies incubation for 1 h at room temperature. Relative expression of
speciﬁc immunoreactive band was calculated by comparing
the ﬂuorescence intensities in an Odyssey infrared imaging
system (LI-COR) with respect to corresponding GAPDH.
Luciferase reporter assay for promoter activity
Three micrograms per milliliter of SLC44A4, SLC19A2, and
SLC19A3 full-length as well as minimal promoter constructs
(previously cloned and characterized in our laboratory;
(45–47)) together with 100 ng of thymidine kinase promoterRenilla luciferase plasmid (Promega) were transiently transfected into human colonic epithelial NCM460 cells utilizing
Lipofectamine 2000 reagent (obtained from Life Technologies)
for a period of 48 h, as described previously (45–47, 50). Cells
were then exposed to chamber-induced hypoxic or normoxic
conditions for additional 16 h and then lysed with passive lysis
buffer for further analysis. All Renilla-normalized ﬁreﬂy
luciferase promoter activities were assessed utilizing a Glomax
20/20 Luminometer (Promega) using the dual-luciferase assay
system (Promega).
Statistical analysis
All carrier-mediated TPP and thiamin uptake, qPCR,
immunoblotting quantiﬁcation, and luciferase reporter assay
data were calculated as means ± standard error. The graphical
data in all the ﬁgures were presented as percentage relative to
simultaneously performed controls using GraphPad Prism 8
software (GraphPad Software, Inc). Statistical analyses were
carried out by unpaired Student’s t test, and p < 0.05 was
considered as being statistically signiﬁcant.
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